4Bayraktar Y, Koeeoglu T, Temizer A, et al. Relationship between the serum alanine aminotranaferase level at the end of interferon and histologic changes in wild - type and precore mutant hepatitis B virus infection[J]. J Viral Hepatol, 1996; 3 (3):137 - 140.
5Barton AL, Banner BF, Cable EE, et al. Distribution of iron in the liver predicts the response of hepatitis C infection to interferon therapy[J]. Am J Clin Pathol, 1995; 103:419 - 424.
6Iancu TC, Deugnier Y, Halliday JW, et al. Morphlogic characteristics of HBV markers and products of iron metabolism in liver tissue inpatients with hepatitis B virus[J]. Vojnosanit pregl, 1992,49(3):477
7Ishida M, Nakagawara G, Imanura Y, et al. Iron and copper deposition in chronic active hepatitis and liver cirrhosis: pathogenetic role in progressive liver cell danage[J] .Eur J Histochem, 1995,39(3):221
8Cable EE,Connor JR, Ison, et al.Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediatedby no-transferrin-bound forms of iron[J]. Am J Pathol, 1998,152(3): 781.
9Akiyoshi F, Stata M, Uchimura Y, et al. Hepatic iron staings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy[J] .Am J Gastroenterol, 1997,92(9): 1463
10Olynyk JK, Reddy KR, Di-Bisceglie AM, et al. Hepatic iron concentration as a predictor to interferon alfa therapy in chronic hepatitis C[J]. Gastroenterology, 1995,108(4): 1104
